Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03610269 · ClinicalTrials.gov registry record · NA
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation of INVSENSOR00026
A NA study of Anemia, sponsored by Masimo Corporation.
- Completed
- Registry status
- NA
- Development phase
- 143
- Enrollment target
- 1
- Study location
NCT03610269: Completed NA study of Anemia, sponsored by Masimo Corporation.
NCT03610269 is a NA study of Anemia that has completed, run by Masimo Corporation. The registered enrollment target is 143 participants, below the 426-participant average among 72 other Anemia trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03610269, a NA study of Anemia, has completed, sponsored by Masimo Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 143 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this clinical investigation is to evaluate the accuracy of using Masimo's INVSENSOR00026 Pulse CO-Oximeter and Sensor to measure hemoglobin, as compared to hemoglobin measurements obtained from various lab analyzer(s) and point of care device(s).
Primary Outcome
Accuracy of the INVSENSOR00026 will be determined by comparing the noninvasive hemoglobin measurement (SpHb) of the INVSENSOR00026 to the hemoglobin value obtained from a reference blood sample and calculating the accuracy root mean square (Arms) error value. In order to obtain the Arms value, the blood sample hemoglobin value is subtracted from the INVSENSOR00026 hemoglobin value for a number of samples, the average of this difference is computed as the bias. The standard deviation of the diffe
Conditions Studied
Interventions
- DEVICE INVSENSOR00026 (Pulse CO-Oximeter and sensor)
Study Locations (1)
California
- Torrance Clinical Research - Lomita
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 143 participants |
| Start Date | 2018-08-01 |
| Est. Completion | 2018-08-16 |
| Phase | NA |
What the finished NCT03610269 record still lists
NCT03610269 is an interventional study that assigns participants to a tested intervention. The registered 143 participants enrollment target is mid-sized for trials with a published cap, below the 426-participant average among 72 other Anemia trials with a reported enrollment target (66% lower).
The record links to 1 condition, with Anemia appearing as the primary indexed condition, and to 1 intervention - of which INVSENSOR00026 (Pulse CO-Oximeter and sensor) is the first listed.
NCT03610269 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03610269 about?
NCT03610269 is a clinical study titled "Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation of INVSENSOR00026". The primary objective of this clinical investigation is to evaluate the accuracy of using Masimo's INVSENSOR00026 Pulse CO-Oximeter and Sensor to measure hemoglobin, as compared to hemoglobin measurements obtained from various lab analyzer(s) and point of care device(s).
What is the current status of trial NCT03610269?
This trial is currently completed. It is a NA study. The enrollment target is 143 participants. The study started on 2018-08-01. Estimated completion is 2018-08-16.
What conditions does trial NCT03610269 study?
This clinical trial studies the following conditions: Anemia.
What interventions are being tested in trial NCT03610269?
The interventions under investigation include: INVSENSOR00026 (Pulse CO-Oximeter and sensor) (DEVICE).
Who is sponsoring clinical trial NCT03610269?
This trial is sponsored by Masimo Corporation, which has 96 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03610269 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03610269's enrollment target sits among peer trials
143 40th of 72 higher than 33 of 72 other Anemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Kids With Iron Deficiency and Scoliosis
RECRUITING · NA
-
Effectiveness of Small Phlebotomy Tubes in Reducing Blood Transfusions in Adult Medical Intensive Care Unit and Intermediate Care Unit Patients With Anemia
RECRUITING · NA
-
A New Combination of Evidence-Based Interventions to Improve Primary Care Diagnostic Safety and Efficiency
RECRUITING · NA
-
The Immediate and Long-term Effects of a Novel Marine-based Iron Supplement in Adult Females
ACTIVE NOT RECRUITING · NA
-
Effects of Vitamin D and Marine Omega-3 Fatty Acids on Anemia
ACTIVE NOT RECRUITING · NA
-
Placental Transfusion in Term Infants: A Pilot Study
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01861106 · 144 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
- NCT03482245 · 144 participants · NA
The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
- NCT03504683 · 144 participants · NA
MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes
- NCT03905603 · 144 participants · Early Phase 1
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI